TIA
BMY icon

Traphagen Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Traphagen Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
3,502
+11
+0.3% +$632 0.01% 208
2026
Q1 		$212K Buy
+3,491
New +$204K 0.02% 190
2023
Q4 		– Sell
-3,480
Closed -$202K – 176
2023
Q3 		$202K Buy
3,480
+230
+7% +$14.1K 0.03% 155
2023
Q2 		$208K Buy
3,250
+13
+0.4% +$872 0.03% 149
2023
Q1 		$224K Buy
3,237
+12
+0.4% +$846 0.03% 141
2022
Q4 		$232K Buy
3,225
+123
+4% +$9.27K 0.04% 136
2022
Q3 		$221K Buy
3,102
+10
+0.3% +$725 0.04% 127
2022
Q2 		$238K Buy
3,092
+56
+2% +$4.26K 0.04% 122
2022
Q1 		$222K Buy
3,036
+1,796
+145% +$121K 0.04% 128
2021
Q4 		$227K Hold
1,240
– – 0.04% 127
2021
Q3 		$207K Hold
1,240
– – 0.04% 131
2021
Q2 		$200K Sell
1,240
-2,673
-68% -$174K 0.03% 136
2021
Q1 		$247K Buy
3,913
+88
+2% +$5.47K 0.05% 119
2020
Q4 		$237K Sell
3,825
-87
-2% -$5.35K 0.04% 118
2020
Q3 		$236K Sell
3,912
-138
-3% -$8.31K 0.05% 108
2020
Q2 		$238K Sell
4,050
-47
-1% -$2.81K 0.05% 108
2020
Q1 		$228K Buy
+4,097
New +$250K 0.06% 105

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Traphagen Investment Advisors's BMY Position: Q2 2026 in Review

Traphagen Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.32% in Q2 2026, buying an estimated $632 and bringing the position to 3,502 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #208.

Traphagen Investment Advisors first reported a position in BMY in Q1 2020 and has held it in 17 quarters since. The position peaked at $247K in Q1 2021. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Traphagen Investment Advisors held 3,502 shares of Bristol-Myers Squibb worth $202K as of Q2 2026.
  • Traphagen Investment Advisors bought 11 Bristol-Myers Squibb shares in Q2 2026, an estimated $632.
  • Bristol-Myers Squibb made up 0.01% of Traphagen Investment Advisors's portfolio in Q2 2026, its #208 holding.
  • Traphagen Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 17 quarters since.
  • Traphagen Investment Advisors's Bristol-Myers Squibb position peaked at $247K in Q1 2021.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.